A phase II study of UCN-01 in combination with topotecan in patients with advanced ovarian cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2015
At a glance
- Drugs UCN 01 (Primary) ; Topotecan
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 26 Sep 2005 New trial record.